Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

‘Popcorn thrombus’: a case of massive intracardiac thromboembolism
Driver, Steven, Jouni, Hayan, McCully, Robert B. , Driver, Steven L

Heart | July 31, 2013 | Volume: 100 | Issue: 6 | Pages: 520-521

10.1136/heartjnl-2013-304582 | PMID 23899785 Get It

AARC Clinical Practice Guideline: Blood Gas Analysis and Hemoximetry: 2013
Davis, Michael D. , Walsh, Brian K , Sittig, Steve E, Sittig, Steven E., Restrepo, Ruben D

Respiratory Care | July 31, 2013 | Volume: 58 | Issue: 10 | Pages: 1694-1703

10.4187/respcare.02786 | PMID 23901131 Get It

We searched MEDLINE, CINAHL, and Cochrane Library database for articles published between January 1990 and December 2012. The update of this clinical practice guideline is based on 237 clinical trials, 54 reviews, and 23 meta-analyses on blood gas analysis (BGA) and hemoximetry. The following recommendations are made following the Grading of Recommendations Assessment, Development, and Evaluation scoring system. BGA and hemoximetry are recommended for evaluating a patient's ventilatory, acid-base, and/or oxygenation status. BGA and hemoximetry are suggested for evaluating a patient's response to therapeutic interventions. BGA and hemoximetry are recommended for monitoring severity and progression of documented cardiopulmonary disease processes. Hemoximetry is recommended to determine the impact of dyshemoglobins on oxygenation. Capillary BGA is not recommended to determine oxygenation status. Central venous BGA and hemoximetry are suggested to determine oxygen consumption in the setting of early goal-directed therapies. For the assessment of oxygenation, a peripheral venous P O 2 is not recommended as a substitute for an arterial blood measurement (P aO 2 ). It is not recommended to use venous P CO 2 and pH as a substitute for arterial blood measurement of P aCO 2 and pH. It is suggested that hemoximetry is used in the detection and evaluation of shunts during diagnostic cardiac catheterization.
Denosumab Chemotherapy for Recurrent Giant-Cell Tumor of Bone: A Case Report of Neoadjuvant Use Enabling Complete Surgical Resection
Agarwal, Amit , Larsen, Brandon T. , Buadu, Lawrence Danso, Dunn, Jack , Crawford, Russell M. , Bishop, Maria C., Daniel, Jonathan C.

Case Reports in Oncological Medicine | July 30, 2013 | Volume: 2013 | Issue: No issue available | Pages: 1-4

10.1155/2013/496351 | PMID 23984138 Get It

Giant-cell tumor of the bone (GCTB) is a rare neoplasm that affects young adults. The tumor is generally benign but sometimes can be locally aggressive. There are no standardized approaches to the treatment of GCTB. Recently, the RANKL inhibitor denosumab has shown activity in this tumor type. We present the case of a young female who presented with locally advanced disease and was successfully managed with the neoadjuvant use of denosumab allowing for surgical resection of the tumor that was previously deemed unresectable. Following surgery, the patient is being managed with continued use of denosumab as ‘maintenance,’ and she continues to be free of disease. Our case highlights a novel approach for the management of locally advanced and aggressive giant cell tumor of the bone.
Effectiveness of PET/CT in the preoperative evaluation of neck disease
Nguyen, Anthony , Luginbuhl, Adam , Cognetti, David M. , Abel, Katie Van, Bar‐Ad, Voichita , Intenzo, Charles , Keane, William M., Curry, Joseph

The Laryngoscope | July 30, 2013 | Volume: 124 | Issue: 1 | Pages: 159-164

10.1002/lary.24329 | PMID 23901035 Get It

Objectives/HypothesisTo evaluate the utility of positron emission tomography (PET)/computed tomography (CT) for staging the neck in the preoperative setting by comparing it to both CT/magnetic resonance imaging (MRI) and pathologic staging.Study DesignRetrospective review.MethodsSeventy‐one patients with initial diagnosis of head and neck squamous cell carcinoma having preoperative MR or CT imaging and PET/CT with subsequent bilateral neck dissection as part of primary treatment (142 neck dissections). Comparison of cervical nodal metastases based on three separate staging systems: preoperative CT and/or MRI scan, preoperative PET/CT, and pathology.ResultsBoth CT/MRI scans and PET/CT scans statistically predicted pathologic outcomes (P = 0.0001, P = 0.0001, respectively) using Chi square analysis. There was a statistically significant improvement in the prediction of true pathologic disease using PET/CT compared to CT and/or MRI alone (P = 0.005). In a subgroup analysis including only the contralateral neck, this significance persisted (P = 0.013). McNemar's test revealed that subsequent detection of bilateral neck disease by PET/CT scan was significantly superior to MRI or CT alone (P = 0.023).ConclusionIn pathologically positive necks, PET/CT was statistically more reliable at identifying positive disease than CT or MRI alone. Furthermore, such a result is achieved without a statistically significant difference in false positivity between PET/CT and CT or MRI. This suggests that PET/CT positivity, despite negative clinical exam and CT/MRI findings, may be more likely to signify pathologic disease and require appropriate treatment.Level of Evidence4. Laryngoscope, 124:159–164, 2014
Efficacy of Acupuncture for Chronic Constipation: A Systematic Review
Zhang, Tao , Chon, Tony Y. , Do, Alexander , Li, Guangxi , Bauer, Brent A. , Wang, Linpeng , Liu, Baoyan , Liu, Zhishun , Li, Guangxi

The American Journal of Chinese Medicine | July 30, 2013 | Volume: 41 | Issue: 04 | Pages: 717-742

10.1142/s0192415x13500493 | PMID 23895148 Get It

This study was to evaluate the efficacy and safety of acupuncture for chronic functional constipation. Randomized controlled trials were searched in several databases. The primary outcome was a change in the number of weekly spontaneous bowel movements. The secondary outcomes included colonic transit activity, effective rate, Cleveland Clinic Score, and health-related quality of life score. Meta-analysis was done by using RevMan 5.1. After strict screening, 15 RCTs were included, containing 1256 participants. All of them were conducted in China and published in Chinese journals. Meta-analysis indicated that acupuncture for chronic functional constipation was probably as effective as conventional medical therapy in the change of bowel movements. For the colonic transit activity, acupuncture might be the same as conventional medical therapy and could be better than sham acupuncture. For the Cleveland Clinic Score, acupuncture was unlikely inferior to conventional medical therapy and the deep acupuncture was better than normal depth acupuncture in abdominal region. No obvious adverse event was associated with acupuncture for constipation. In conclusion, acupuncture for chronic functional constipation is safe and may improve weekly spontaneous bowel movements, quality of life, and relevant symptoms. However, the evidence was limited by the small sample size and the methodological quality.
The Integration of Studio Cycling into a Worksite Stress Management Programme
Clark, Matthew M. , Soyring, Jason E., Jenkins, Sarah M. , Daniels, Denise C., Berkland, Bridget E., Werneburg, Brooke L., Hagen, Philip T., Warren, Beth A., Olsen, Kerry D., López-Jiménez, Francisco

Stress and Health | July 30, 2013 | Volume: 30 | Issue: 2 | Pages: 166-176

10.1002/smi.2514 | PMID 23897838 Get It

AbstractHigh stress is a prevalent problem in the worksite. To reduce stress, improve productivity, reduce absenteeism, and lower healthcare costs, many companies offer exercise classes or stress management programmes. Although physical activity is an important component of stress management, few worksites have integrated physical activity into their comprehensive stress reduction programmes. The purpose of this single‐arm pilot project was to examine the potential effectiveness of an integrated exercise (studio cycling) and cognitive–behavioural stress management programme. Eighty‐four adults, 75% female, mostly aged 40+ years, participated in an integrated 12‐week cycling studio and cognitive–behavioural stress management programme. Participants experienced a significant and clinically meaningful reduction on the Perceived Stress Scale (p < 0.01), rating of current stress level and confidence to manage stress at the programme's end and at a 1‐month follow‐up. Participants also reported having significantly improved overall health, improved nutritional habits, higher physical activity level, greater confidence in their ability to follow a healthy diet, higher spiritual well‐being, improved sleep, receiving more support for maintaining healthy living and improved quality of life at the completion of the 12‐week programme and 1‐month follow‐up. These findings provide further support for an integrated exercise and stress management programme. Copyright © 2013 John Wiley & Sons, Ltd.
Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource
Link, Brian K. , Maurer, Matthew J. , Nowakowski, Grzegorz S. , Ansell, Stephen M. , Macon, William R. , Syrbu, Sergei , Thompson, Carrie A. , Inwards, David J. , Johnston, Patrick B. , Cerhan, James R. , Slager, Susan L. , Colgan, Joseph P. , Witzig, Thomas E. , Habermann, Thomas M. , Maurer, Matthew , Cerhan, James R , Link, Brian K , Syrbu, Sergei

Journal of Clinical Oncology | July 30, 2013 | Volume: 31 | Issue: 26 | Pages: 3272-3278

10.1200/jco.2012.48.3990 | PMID 23897955 Get It

Purpose This study sought to characterize transformation incidence and outcome for patients with follicular lymphoma (FL) in a prospective observational series begun after diffusion of rituximab use. Patients and Methods Patients with newly diagnosed FL were prospectively enrolled onto the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource from 2002 to 2009. Patients were actively followed for re-treatment, clinical or pathologic transformation, and death. Risk of transformation was analyzed via time to transformation by using death as a competing risk. Results In all, there were 631 patients with newly diagnosed grade 1 to 3a FL who had a median age at enrollment of 60 years. At a median follow-up of 60 months (range, 11 to 110 months), 79 patients had died, and 60 patients developed transformed lymphoma, of which 51 were biopsy proven. The overall transformation rate at 5 years was 10.7%, with an estimated rate of 2% per year. Increased lactate dehydrogenase was associated with increased risk of transformation. Transformation rate at 5 years was highest in patients who were initially observed and lowest in patients who initially received rituximab monotherapy (14.4% v 3.2%; P = .021). Median overall survival following transformation was 50 months and was superior in patients with transformation greater than 18 months after FL diagnosis compared with patients with earlier transformation (5-year overall survival, 66% v 22%; P < .001). Conclusion Follicular transformation rates in the immunochemotherapy era are similar to risk of death without transformation and may be lower than reported in older series. Post-transformation prognosis is substantially better than described in older series. Initial management strategies may influence the risk of transformation.
Temporal Elements in Career Selection Decisions: An Archival Study Investigating Career Decisions in Medicine
Shah, Priti Pradhan , Bechara, John P. , Kolars, Joseph C. , Drefahl, Monica M., Wood, Douglas L. , Spurrier, Barbara R., Shah, Pri Pradhan , LaRusso, Nicholas F.

Organization Science | July 30, 2013 | Volume: 25 | Issue: 1 | Pages: 245-261

10.1287/orsc.2013.0838 Get It

Time is a ubiquitous but often omitted variable in career selection decisions. This study investigates the impact of temporal elements on career selection decisions, thus advancing our understanding of both career decision making and the impact of timing on decision making. We investigate the influence of timing and duration of experience with career options on career selection decisions in an archival study using medical residents’ rotation schedules. We also investigate factors that mitigate the influence of timing on career selection decisions by examining the interaction of timing with the duration of experience and the diversity of options that an individual experiences. Conditional logit results indicate that decisions often based on career and individual attributes are significantly influenced by the timing and duration of options even when controlling for option attributes. Additionally, significant interactions between timing and diversity of experience and timing and duration of experience revealed boundary conditions for timing. Individuals were more likely to select later-appearing career options when they appeared for a greater duration or when they experienced a greater diversity of options in their schedule. Results illustrate that schedules over which individuals have no control can influence consequential decisions.
Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma
Smith, Sonali M. , Burns, Linda J. , He, Wensheng , Fenske, Timothy S. , Suzuki, Ritsuro , Hsu, Jack W., Schouten, Harry C. , Hale, Gregory A., Holmberg, Leona , Sureda, Anna , Freytes, César O. , Inwards, David J. , Gross, Thomas G. , Cairo, Mitchell S. , Costa, Luciano J. , Wiernik, Peter H. , Maharaj, Dipnarine , Laport, Ginna G. , Montoto, Silvia , Hari, Parameswaran , Holmberg, Leona , Besien, Koen van , Le‐Rademacher, Jennifer , Maziarz, Richard Thomas , Gale, Robert Peter , Lazarus, Hillard M. , Montoto, Silvia , Costa, Luciano J , Hari, Parameswaran

Journal of Clinical Oncology | July 30, 2013 | Volume: 31 | Issue: 25 | Pages: 3100-3109

10.1200/jco.2012.46.0188 | PMID 23897963 Get It

Purpose To analyze outcomes of hematopoietic cell transplantation (HCT) in T-cell non-Hodgkin lymphoma. Patients and Methods Outcomes of 241 patients (112 anaplastic large-cell lymphoma, 102 peripheral T-cell lymphoma not otherwise specified, 27 angioimmunoblastic T-cell lymphoma) undergoing autologous HCT (autoHCT; n = 115; median age, 43 years) or allogeneic HCT (alloHCT; n = 126; median age, 38 years) were analyzed. Primary outcomes were nonrelapse mortality (NRM), relapse/progression, progression-free survival (PFS), and overall survival (OS). Patient, disease, and HCT-related variables were analyzed in multivariate Cox proportional hazard models to determine association with outcomes. Results AutoHCT recipients were more likely in first complete remission (CR1; 35% v 14%; P = .001) and with chemotherapy-sensitive disease (86% v 60%; P < .001), anaplastic large-cell histology (53% v 40%; P = .04), and two or fewer lines of prior therapy (65% v 44%; P < .001) compared with alloHCT recipients. Three-year PFS and OS of autoHCT recipients beyond CR1 were 42% and 53%, respectively. Among alloHCT recipients who received transplantations beyond CR1, 31% remained progression-free at 3 years, despite being more heavily pretreated and with more refractory disease. NRM was 3.5-fold higher (95% CI, 1.80 to 6.99; P < .001) for alloHCT. In multivariate analysis, chemotherapy sensitivity (hazard ratio [HR], 1.8; 95% CI, 1.16 to 2.87) and two or fewer lines of pretransplantation therapy (HR, 5.02; 95% CI, 2.15 to 11.72) were prognostic of survival. Conclusion These data describe the roles of autoHCT and alloHCT in T-cell non-Hodgkin lymphoma and suggest greater effectiveness earlier in the disease course, and limited utility in multiply relapsed disease. Notably, autoHCT at relapse may be a potential option for select patients, particularly those with anaplastic large-cell lymphoma histology.
HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation
Baker, Jason V. , Brummel‐Ziedins, Kathleen E., Neuhaus, Jacqueline, Dalmau, David , Lehmann, Clara , Sullivan, Ann , Woolley, Ian , Kuller, Lewis H. , Neaton, James D. , Team, INSIGHT SMART Study, Duprez, Daniel A. , Cummins, Nathan W. , DeHovitz, Jack A. , Tracy, Russell P. , Team, INSIGHT SMART Study, Nordwall, Jacqueline

Journal of the American Heart Association | July 29, 2013 | Volume: 2 | Issue: 4 | Pages: No page available

10.1161/jaha.113.000264 | PMID 23896681 Get It

Background HIV infection leads to activation of coagulation, which may increase the risk for atherosclerosis and venous thromboembolic disease. We hypothesized that HIV replication increases coagulation potentially through alterations in extrinsic pathway factors. Methods and Results Extrinsic pathway factors were measured among a subset of HIV participants from the Strategies for Management of Anti‐Retroviral Therapy ( SMART ) trial. Thrombin generation was estimated using validated computational modeling based on factor composition. We characterized the effect of antiretroviral therapy ( ART ) treatment versus the untreated state ( HIV replication) via 3 separate analyses: (1) a cross‐sectional comparison of those on and off ART (n=717); (2) a randomized comparison of deferring versus starting ART (n=217); and (3) a randomized comparison of stopping versus continuing ART (n=500). Compared with viral suppression, HIV replication consistently showed short‐term increases in some procoagulants (eg, 15% to 23% higher FVIII ; P <0.001) and decreases in key anticoagulants (eg, 5% to 9% lower antithrombin [ AT ] and 6% to 10% lower protein C; P <0.01). The net effect of HIV replication was to increase coagulation potential (eg, 24% to 48% greater thrombin generation from computational models; P <0.01 for all). The pattern of changes from HIV replication was reversed with ART treatment and consistent across all 3 independent comparisons. Conclusions HIV replication leads to complex changes in extrinsic pathway factors, with the net effect of increasing coagulation potential to a degree that may be clinically relevant. The key influence of changes in FVIII and AT suggests that HIV ‐related coagulation abnormalities may involve changes in hepatocyte function in the context of systemic inflammation. Clinical Trial Registration URL: ClinicalTrials.gov . Unique identifier: NCT 00027352.